FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Activated Insights Announces 2025 Customer Experience Award™ Winners, Recognizing Excellence in Long-Term and Post-Acute Care
Activated Insights, the leading provider of training, recruitment, retention, experience management and recognition tools to ...
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for moderate to ...
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
FDA approves painkiller designed to eliminate the risks of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Cure Today2h
Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...
Funding announcement for RVH will see acute care and complex continuing care units upgraded
Calling it a “game changer” for Renfrew Victoria Hospital (RVH), Renfrew-Nipissing-Pembroke MPP John Yakabuski said the ...
New Study Published in JAMA Network Open Finds Procedural Prescription Denials Can Increase Acute Care Utilization and Spending in Medicaid
A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result in increased acute care utilization and costs, which ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...